High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

There are > 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of action currently approved by the US Food and Drug Administration for the treatment of relapsing–remitting multiple sclerosis (RRMS). Given the multitude of available treatment options, and recent internation...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Léorah, Longbrake, Erin E., Coyle, Patricia K., Hendin, Barry, Vollmer, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645316/
https://www.ncbi.nlm.nih.gov/pubmed/36350491
http://dx.doi.org/10.1007/s40263-022-00965-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645316/
https://www.ncbi.nlm.nih.gov/pubmed/36350491
http://dx.doi.org/10.1007/s40263-022-00965-7

Ejemplares similares